Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-1,41%
1 076,13
-15,38
-1,41%
—1 091,511 090,401 090,401 073,69——
SIXC
Communications
SIXC
Communications
SIXC
-0,55%
606,74
-3,37
-0,55%
—610,11610,11610,29606,17——
SIXE
Energy
SIXE
Energy
SIXE
+0,88%
1 248,82
+10,84
+0,88%
—1 237,981 237,831 252,411 225,03——
SIXI
Industrials
SIXI
Industrials
SIXI
-1,17%
1 724,36
-20,35
-1,17%
—1 744,711 740,951 747,291 721,57——
SIXM
Financials
SIXM
Financials
SIXM
-0,72%
635,59
-4,59
-0,72%
—640,18639,92643,19634,73——
SIXR
Staples
SIXR
Staples
SIXR
-0,76%
843,15
-6,43
-0,76%
—849,58845,27851,68839,47——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0,55%
216,29
-1,19
-0,55%
—217,48217,48218,16215,51——
SIXT
Technology
SIXT
Technology
SIXT
+0,08%
3 263,41
+2,72
+0,08%
—3 260,693 273,363 287,813 240,78——
SIXU
Utilities
SIXU
Utilities
SIXU
-0,34%
939,24
-3,21
-0,34%
—942,45939,39948,80933,98——
SIXV
Health care
SIXV
Health care
SIXV
-0,29%
1 462,56
-4,24
-0,29%
—1 466,801 464,701 467,191 458,36——
SIXY
Discretionary
SIXY
Discretionary
SIXY
-0,71%
2 380,40
-17,10
-0,71%
—2 397,502 395,032 412,012 370,64——
CVG:FRA
CSPC Pharmaceutical Group Ltd
0,91 €
+1,93%
(+0,017) 1D
4 მაი, 22:00:00 GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for CVG...
Open
0,91 €
High
0,91 €
Low
0,91 €
Mkt. cap
97,79 მლრდ.
Avg. vol.
94,00
Volume
0,00
52-wk high
1,25 €
52-wk low
0,63 €
No. of employees
20 ათ.
News stories
From sources across the web
TechStock²
TechStock²
·
47 წუთის წინ
Dow Drops 557 Points as Oil Shock Hits US Stocks; Palantir Slides After Hours
TipRanks
TipRanks
·
1 საათის წინ
Why Is SPDR S&P 500 ETF Trust (SPY) Down Today, 5/4/2026?
PR Newswire
PR Newswire
·
2 საათის წინ
Cambium Networks Pursues Appeal of Nasdaq Delisting
Seeking Alpha
Seeking Alpha
·
2 საათის წინ
The 4 Effects Pumping S&P 500 And Tech/AI Earnings (NYSEARCA:SPY)
Profile
CSPC Pharmaceutical Group researches, develops, manufactures and sells pharmaceutical products. Its headquarters is in China's Hebei Province. CSPC produces both active pharmaceutical ingredient and formulations. API products include penicillin, cefalosporins, synthetic vitamins, caffeine and ranitidine. Formulations include antibiotics, butylphthalide and analgesics, in addition to nearly 1,000 other products. CSPC's 15,000 employees are divided among more than ten subsidiaries, including CSPC Zhongrun, Weisheng, Zhongnuo and NBP. CSPC Pharma's total assets are valued above RMB 8 billion. In 2007, CSPC Pharma achieved sales of RMB 8 billion and net income of RMB 485 million. Direct exports of US$300 million ranked CSPC first among China's pharmaceutical enterprises. One subsidiary, China Pharmaceutical Group Co., Ltd is based in Hong Kong. It is listed on the Hang Seng China-Affiliated Corporations Index. In 2003 and 2004, China Pharma was listed as one of 100 excellent listed companies with turnover less than $1 billion. CSPC Pharma is recognized as one of China's “500 Most Valuable Chinese Brands” and “Top 500 Chinese Enterprises.” Wikipedia
About CSPC Pharmaceutical Group Ltd
CEOZhang Cuilong
Employees19,7 ათ.
Founded1992
Headquarters-
SectorPharmaceutical industry
Websitecspc.com.hk
Previous reportsAll values in HKD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
მარ. 2025
ივნ. 2025
სექ. 2025
დეკ. 2025
Revenue
7,01 მლრდ.
6,26 მლრდ.
6,62 მლრდ.
6,11 მლრდ.
Cost of goods sold
2,31 მლრდ.
2,25 მლრდ.
2,28 მლრდ.
2,11 მლრდ.
Cost of revenue
2,31 მლრდ.
2,25 მლრდ.
2,28 მლრდ.
2,11 მლრდ.
Research and development expenses
1,30 მლრდ.
1,38 მლრდ.
1,50 მლრდ.
1,62 მლრდ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,89 მლრდ.
1,56 მლრდ.
1,97 მლრდ.
1,87 მლრდ.
Operating expense
3,19 მლრდ.
2,94 მლრდ.
3,47 მლრდ.
3,49 მლრდ.
Total operating expenses
5,50 მლრდ.
5,20 მლრდ.
5,75 მლრდ.
5,60 მლრდ.
Operating income
1,51 მლრდ.
1,06 მლრდ.
869,63 მლნ.
514,71 მლნ.
Other non operating income
278,47 მლნ.
3,60 მლნ.
645,49 მლნ.
-470,42 მლნ.
EBT including unusual items
1,80 მლრდ.
1,32 მლრდ.
1,18 მლრდ.
505,59 მლნ.
EBT excluding unusual items
1,80 მლრდ.
1,14 მლრდ.
1,37 მლრდ.
186,56 მლნ.
Income tax expense
301,26 მლნ.
242,36 მლნ.
222,47 მლნ.
165,64 მლნ.
Effective tax rate
16,77%
18,34%
18,78%
32,76%
Other operating expenses
-
-
-
-
Net income
1,48 მლრდ.
1,07 მლრდ.
963,54 მლნ.
370,72 მლნ.
Net profit margin
21,07%
17,09%
14,56%
6,06%
Earnings per share
-
-
-
-
Interest and investment income
-
95,00 მლნ.
-
195,87 მლნ.
Interest expense
-6,74 მლნ.
-14,91 მლნ.
-105,19 მლნ.
-6,76 მლნ.
Net interest expenses
-6,74 მლნ.
80,09 მლნ.
-105,19 მლნ.
189,12 მლნ.
Depreciation and amortization charges
-
-
-
-
EBITDA
1,79 მლრდ.
1,36 მლრდ.
1,14 მლრდ.
802,06 მლნ.
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer